MARKSANS PHARMA LTD. - 524404 - Announcement under Regulation 30 (LODR)-Daily Buy Back of equity shares
Please find attached daily report pursuant to Regulation 18 of Buyback Regulations26-08-2022
26-08-2022
MARKSANS PHARMA LTD. - 524404 - Announcement under Regulation 30 (LODR)-Daily Buy Back of equity shares
Please find attached daily report pursuant to Regulation 18 of Buyback Regulations24-08-2022
MARKSANS PHARMA LTD. - 524404 - Announcement under Regulation 30 (LODR)-Daily Buy Back of equity shares
Please find attached daily report pursuant to Regulation 18 of Buyback Regulations22-08-2022
Buy Marksans Pharma; target of Rs 80: Arihant Capital
Arihant Capital is bullish on Marksans Pharma has recommended buy rating on the stock with a target price of Rs 80 in its research report dated August 19, 2022.20-08-2022
MARKSANS PHARMA LTD. - 524404 - Extinguishment Of Equity Shares Pursuant To Buyback
Details of Equity Shares extinguished by the Company are enclosed.19-08-2022
MARKSANS PHARMA LTD. - 524404 - Announcement under Regulation 30 (LODR)-Daily Buy Back of equity shares
Please find attached daily report pursuant to Regulation 18 of Buyback Regulations19-08-2022
MARKSANS PHARMA LTD. - 524404 - Announcement under Regulation 30 (LODR)-Earnings Call Transcript
Transcript of Q1FY23 Earnings Conference Call held on August 16, 2022.19-08-2022
MARKSANS PHARMA LTD. - 524404 - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcome
Audio recording of Q1FY23 Results Conference Call is hosted on the website of the Company at http://marksanspharma.com/investors-meet.html17-08-2022
MARKSANS PHARMA LTD. - 524404 - Announcement under Regulation 30 (LODR)-Daily Buy Back of equity shares
Please find attached daily report pursuant to Regulation 18 of Buyback Regulations16-08-2022